These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33862250)

  • 1. Tumor hypoxia: The major culprit behind cisplatin resistance in cancer patients.
    Devarajan N; Manjunathan R; Ganesan SK
    Crit Rev Oncol Hematol; 2021 Jun; 162():103327. PubMed ID: 33862250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-Induced Resistance to Chemotherapy in Cancer.
    Minassian LM; Cotechini T; Huitema E; Graham CH
    Adv Exp Med Biol; 2019; 1136():123-139. PubMed ID: 31201721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia promotes acquisition of aggressive phenotypes in human malignant mesothelioma.
    Kim MC; Hwang SH; Kim NY; Lee HS; Ji S; Yang Y; Kim Y
    BMC Cancer; 2018 Aug; 18(1):819. PubMed ID: 30111297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancer-bound Nrf2 licenses HIF-1α transcription under hypoxia to promote cisplatin resistance in hepatocellular carcinoma cells.
    Jin X; Gong L; Peng Y; Li L; Liu G
    Aging (Albany NY); 2020 Dec; 13(1):364-375. PubMed ID: 33290263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scriptaid overcomes hypoxia-induced cisplatin resistance in both wild-type and mutant p53 lung cancer cells.
    Pradhan S; Mahajan D; Kaur P; Pandey N; Sharma C; Srivastava T
    Oncotarget; 2016 Nov; 7(44):71841-71855. PubMed ID: 27708247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allicin Overcomes Hypoxia Mediated Cisplatin Resistance in Lung Cancer Cells through ROS Mediated Cell Death Pathway and by Suppressing Hypoxia Inducible Factors.
    Pandey N; Tyagi G; Kaur P; Pradhan S; Rajam MV; Srivastava T
    Cell Physiol Biochem; 2020 Aug; 54(4):748-766. PubMed ID: 32809300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3/Rab proteins.
    Dorayappan KDP; Wanner R; Wallbillich JJ; Saini U; Zingarelli R; Suarez AA; Cohn DE; Selvendiran K
    Oncogene; 2018 Jul; 37(28):3806-3821. PubMed ID: 29636548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing of GLUT-1 inhibits sensitization of oral cancer cells to cisplatin during hypoxia.
    Shimanishi M; Ogi K; Sogabe Y; Kaneko T; Dehari H; Miyazaki A; Hiratsuka H
    J Oral Pathol Med; 2013 May; 42(5):382-8. PubMed ID: 23227892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia/IL-1α axis promotes gastric cancer progression and drug resistance.
    Xuan Y; Wang YN
    J Dig Dis; 2017 Sep; 18(9):511-520. PubMed ID: 28608600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxic tumor therapy by hemoglobin-mediated drug delivery and reversal of hypoxia-induced chemoresistance.
    Yang J; Li W; Luo L; Jiang M; Zhu C; Qin B; Yin H; Yuan X; Yin X; Zhang J; Luo Z; Du Y; You J
    Biomaterials; 2018 Nov; 182():145-156. PubMed ID: 30121013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-induced cisplatin resistance is reversible and growth rate independent in lung cancer cells.
    Wohlkoenig C; Leithner K; Deutsch A; Hrzenjak A; Olschewski A; Olschewski H
    Cancer Lett; 2011 Sep; 308(2):134-43. PubMed ID: 21669489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorescence monitoring of hypoxic microenvironment in solid-tumors to evaluate chemotherapeutic effects using the hypoxia-sensitive iridium (III) coordination compound.
    Zeng Y; Liu Y; Shang J; Ma J; Wang R; Deng L; Guo Y; Zhong F; Bai M; Zhang S; Wu D
    PLoS One; 2015; 10(3):e0121293. PubMed ID: 25786221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxic tumor microenvironment: Opportunities to develop targeted therapies.
    Patel A; Sant S
    Biotechnol Adv; 2016; 34(5):803-812. PubMed ID: 27143654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-mediated cancer stem cell resistance and targeted therapy.
    Sun X; Lv X; Yan Y; Zhao Y; Ma R; He M; Wei M
    Biomed Pharmacother; 2020 Oct; 130():110623. PubMed ID: 32791395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming hypoxia-induced chemoresistance to cisplatin through tumor oxygenation monitored by optical imaging.
    Song D; Beringhs AO; Zhuang Z; Joshi G; Tran TH; Claffey KP; Yuan H; Lu X
    Nanotheranostics; 2019; 3(2):223-235. PubMed ID: 31183316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. lncMat2B regulated by severe hypoxia induces cisplatin resistance by increasing DNA damage repair and tumor-initiating population in breast cancer cells.
    García-Venzor A; Mandujano-Tinoco EA; Ruiz-Silvestre A; Sánchez JM; Lizarraga F; Zampedri C; Melendez-Zajgla J; Maldonado V
    Carcinogenesis; 2020 Nov; 41(11):1485-1497. PubMed ID: 32710610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy contributes to the chemo-resistance of non-small cell lung cancer in hypoxic conditions.
    Lee JG; Shin JH; Shim HS; Lee CY; Kim DJ; Kim YS; Chung KY
    Respir Res; 2015 Nov; 16():138. PubMed ID: 26553068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herbal nutraceuticals: safe and potent therapeutics to battle tumor hypoxia.
    Nalini D; Selvaraj J; Kumar GS
    J Cancer Res Clin Oncol; 2020 Jan; 146(1):1-18. PubMed ID: 31724069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances In Developing Novel Anti-Cancer Drugs Targeting Tumor Hypoxic and Acidic Microenvironments.
    Li W; Sun X
    Recent Pat Anticancer Drug Discov; 2018; 13(4):455-468. PubMed ID: 30173649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salidroside improves the hypoxic tumor microenvironment and reverses the drug resistance of platinum drugs via HIF-1α signaling pathway.
    Qin Y; Liu HJ; Li M; Zhai DH; Tang YH; Yang L; Qiao KL; Yang JH; Zhong WL; Zhang Q; Liu YR; Yang G; Sun T; Yang C
    EBioMedicine; 2018 Dec; 38():25-36. PubMed ID: 30396856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.